Eltrombopag Cipla

Eltrombopag Cipla is a medication used to stimulate platelet production. It is commonly prescribed for conditions affecting blood cell counts, such as certain types of anemia. This oral medication is manufactured by Cipla Europe NV.

Eltrombopag Cipla is primarily used to increase platelet levels in the blood. It is often prescribed for conditions that result in low platelet counts, which can lead to increased bleeding and bruising. This medication works by stimulating the production of megakaryocytes, the cells responsible for producing platelets. People often ask, 'What is Eltrombopag used for?' and the answer is that it is used to manage conditions that affect platelet production.

Common effects of Eltrombopag Cipla may include nausea, dizziness, and fatigue. Some users may experience changes in vision or hair loss. It is important to discuss any persistent or severe side effects with a healthcare provider. Eltrombopag Cipla is designed to help the body produce more platelets, which can improve overall blood health.

Eltrombopag Cipla should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Eltrombopag Cipla may interact with certain medications, including those that affect liver enzymes. It is important to discuss all current medications with a healthcare provider before starting Eltrombopag Cipla. Alcohol and other substances that affect liver function should be avoided while taking this medication. Always consult a healthcare professional for personalized advice.